A world first in imaging technology

Dr Robert Brkljača and Dr Karen Alt explain the new
Magnetic Particle Imaging facility. See video

Monash University has launched world-first technology that can detect magnetic nanoparticles anywhere in the body, enabling enhanced medical applications such as tracking of beneficial CAR-T cells during cancer therapy.

The new technology was funded through an ARC LIEF grant with contributions from Monash University and RMIT, and combines Magnetic Particle Imaging (MPI) with Computed Tomography (CT) and Hyperthermia capabilities for preclinical, in vivo research. It is located at the Monash Alfred campus and is operated by the Alfred Research Alliance-Monash Biomedical Imaging (ARA-MBI) platform.

15 June 2021 Monash Particle Imaging facility launch

Join us on Tuesday 15 June 2021 for the official virtual launch of Magnetic Particle Imaging at Monash University, a symposium and virtual tour of the facility.

Register here to receive a Zoom link: https://www.eventbrite.com.au/e/official-launch-of-magnetic-particle-imaging-at-monash-university-registration-153244938737

Successful ARC grant for Australia's first Magnetic Particle Imaging facility

"What you see is what you've got". In MPI (far left), SPIO tracers
are bright, not dark, and can be accurately quantified.
Main advantages of MPI over other imaging modalities:
(A) no background signal similar to PET but without the use of radiation,
(B) no tissue signal attenuation as seen with fluorescence imaging, and
(C) no image artefacts as seen in MRI. Image derived from Zheng et al

In the most recent round of Australian Research Council (ARC) grants Monash University was the most successful institution in Victoria.

Professor Terry O'Brien, Head of the Department of Neuroscience and Associate Professor Christoph Hagemeyer, head of the NanoBiotechnology Laboratory at the Australian Centre for Blood Diseases at the Central Clinical School are Chief Investigators on an $898,450 LEIF grant to establish the first Magnetic Particle Imaging (MPI) facility in Australia. The lead investigator is Professor Gary Egan, Director of  Monash Biomedical Imaging.